Multiple Sclerosis Trial, Recruiting NCT05962177 Sponsor: University Hospital, Montpellier Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05962177
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 and younger than 60 years of age
  • People diagnosed with relapsing-remitting MS (a form of MS where symptoms come and go) who have not had a relapse for at least 6 months
  • People whose MS-related disability score (called EDSS) is below 6 at the time of joining, meaning they have a moderate or lower level of physical disability (confirm with trial site)

Who may not be able to join:

  • People whose MS has progressed to a secondary or primary progressive form at the time of joining
  • People showing signs that their MS is getting worse, either through symptoms or brain scans
  • People who have changed their MS treatment within the 6 months before joining
  • People who are unable to have an MRI scan, for example due to claustrophobia or having a pacemaker
  • People who would not be able to attend all the follow-up appointments required by the study
  • Women who are pregnant or breastfeeding
  • People who are not enrolled in, or covered by, the French social security system
  • People who are legally protected or under guardianship or curatorship (a legal arrangement where another person manages someone's affairs)
  • People who have not provided written consent to participate after being given adequate time to consider it

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0467337202

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 September 2023
Est. completion
1 June 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Total brain atrophy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov